Clinical Trial Registered to Investigate Effectiveness of Continuous Glucose Monitoring and Culturally Appropriate Diabetes Care for Pacific Adults

Strategic Insights -

A clinical trial has been registered in Australia to study the effectiveness of continuous glucose monitoring (CGM) and a culturally appropriate primary care pharmacist prescriber model of care in managing type 2 diabetes in Pacific adults. The trial, led by Prof Ben Wheeler, aims to investigate whether the use of CGM and a new model of care for up to 12 months can improve glucose levels and quality of life for participants.

Key Takeaways:

  • The clinical trial, titled "Optimising Type 2 Diabetes Outcomes in Pacific Adults Utilising Continuous Glucose Monitoring and A Culturally Appropriate Primary Care Pharmacist Prescriber Model of Care," is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR) under the number ACTRN12625001114437p.
  • The trial aims to explore the effectiveness of CGM, a technology that has been successfully used in type 1 diabetes for over a decade, in managing type 2 diabetes.
  • Modern real-time CGM systems are more accurate and no longer require finger prick glucose calibration, making them a potentially more effective tool for managing diabetes.
  • The trial will involve a culturally appropriate primary care model of care that includes pharmacist prescribers, dietitians, cultural support workers, and health coaches.
  • The study will last for up to 12 months and will aim to find out whether using CGM and the new model of care can keep glucose levels in a healthy range and improve quality of life for participants.

Statistics:

  • The clinical trial is registered with the Australian New Zealand Clinical Trials Registry (ANZCTR).
  • The trial will last for up to 12 months.
  • The study aims to investigate the effectiveness of continuous glucose monitoring and a culturally appropriate primary care model of care in managing type 2 diabetes.
  • The types of professionals involved in the new model of care include pharmacist prescribers, dietitians, cultural support workers, and health coaches.

Sources:

  • Australian New Zealand Clinical Trials Registry (ANZCTR)
  • https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=390264&isReview=true